Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Development of Neuropathic Post-COVID Pain Symptoms is not Associated with Serological Biomarkers at Hospital Admission in COVID-19 Survivors: A Secondary Analysis.

< BACK TO ARCHIVE


Papers: 4 Jun 2022 - 10 Jun 2022


Human Studies


2022 Jun 08


Pain Med


http://www.ncbi.nlm.nih.gov/pubmed/35674380?dopt=Abstract

Development of Neuropathic Post-COVID Pain Symptoms is not Associated with Serological Biomarkers at Hospital Admission in COVID-19 Survivors: A Secondary Analysis.

Authors

Development of Neuropathic Post-COVID Pain Symptoms is not Associated with Serological Biomarkers at Hospital Admission in COVID-19 Survivors: A Secondary Analysis.
Fernández-de-Las-Peñas C, Herrero-Montes M, Ferrer-Pargada D, Izquierdo-Cuervo S, Palacios-Ceña D, Arendt-Nielsen L, Torres-Macho J, Parás-Bravo P
Pain Med. 2022 Jun 08.
PMID: 35674380.
Read This Paper